[
  {
    "sentence": "Identifying specific genomic changes that drive the transition from normal skin (NS) to AK and subsequently to invasive cSCC is challenging, given the substantial burden of UVR-induced mutations characteristic of all stages of this progression (\nFigure 1\n).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Molecular genetic studies have examined AK and cSCC for known cancer gene expressions, chromosomal instability, and mutation levels (\nFigure 2\n).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Schematic depicting the spectrum of morphologies of NS-AK-cSCC lesions, with relevant changes in gene expression.Figure 2.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Below is an overview of the current clinical drugs used in the management of AK and cSCC (\nFigure 3\n).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Identifying specific genomic changes that drive the transition from normal skin (NS) to AK and subsequently to invasive cSCC is challenging, given the substantial burden of UVR-induced mutations characteristic of all stages of this progression (\nFigure 1\n).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Molecular genetic studies have examined AK and cSCC for known cancer gene expressions, chromosomal instability, and mutation levels (\nFigure 2\n).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Schematic depicting the spectrum of morphologies of NS-AK-cSCC lesions, with relevant changes in gene expression.Figure 2.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Below is an overview of the current clinical drugs used in the management of AK and cSCC (\nFigure 3\n).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Identifying specific genomic changes that drive the transition from normal skin (NS) to AK and subsequently to invasive cSCC is challenging, given the substantial burden of UVR-induced mutations characteristic of all stages of this progression (\nFigure 1\n).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Molecular genetic studies have examined AK and cSCC for known cancer gene expressions, chromosomal instability, and mutation levels (\nFigure 2\n).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Schematic depicting the spectrum of morphologies of NS-AK-cSCC lesions, with relevant changes in gene expression.Figure 2.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Below is an overview of the current clinical drugs used in the management of AK and cSCC (\nFigure 3\n).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Identifying specific genomic changes that drive the transition from normal skin (NS) to AK and subsequently to invasive cSCC is challenging, given the substantial burden of UVR-induced mutations characteristic of all stages of this progression (\nFigure 1\n).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Molecular genetic studies have examined AK and cSCC for known cancer gene expressions, chromosomal instability, and mutation levels (\nFigure 2\n).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Schematic depicting the spectrum of morphologies of NS-AK-cSCC lesions, with relevant changes in gene expression.Figure 2.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Below is an overview of the current clinical drugs used in the management of AK and cSCC (\nFigure 3\n).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Identifying specific genomic changes that drive the transition from normal skin (NS) to AK and subsequently to invasive cSCC is challenging, given the substantial burden of UVR-induced mutations characteristic of all stages of this progression (\nFigure 1\n).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Molecular genetic studies have examined AK and cSCC for known cancer gene expressions, chromosomal instability, and mutation levels (\nFigure 2\n).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Schematic depicting the spectrum of morphologies of NS-AK-cSCC lesions, with relevant changes in gene expression.Figure 2.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Below is an overview of the current clinical drugs used in the management of AK and cSCC (\nFigure 3\n).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Identifying specific genomic changes that drive the transition from normal skin (NS) to AK and subsequently to invasive cSCC is challenging, given the substantial burden of UVR-induced mutations characteristic of all stages of this progression (\nFigure 1\n).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Molecular genetic studies have examined AK and cSCC for known cancer gene expressions, chromosomal instability, and mutation levels (\nFigure 2\n).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Schematic depicting the spectrum of morphologies of NS-AK-cSCC lesions, with relevant changes in gene expression.Figure 2.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Below is an overview of the current clinical drugs used in the management of AK and cSCC (\nFigure 3\n).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Identifying specific genomic changes that drive the transition from normal skin (NS) to AK and subsequently to invasive cSCC is challenging, given the substantial burden of UVR-induced mutations characteristic of all stages of this progression (\nFigure 1\n).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Molecular genetic studies have examined AK and cSCC for known cancer gene expressions, chromosomal instability, and mutation levels (\nFigure 2\n).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Schematic depicting the spectrum of morphologies of NS-AK-cSCC lesions, with relevant changes in gene expression.Figure 2.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Below is an overview of the current clinical drugs used in the management of AK and cSCC (\nFigure 3\n).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Identifying specific genomic changes that drive the transition from normal skin (NS) to AK and subsequently to invasive cSCC is challenging, given the substantial burden of UVR-induced mutations characteristic of all stages of this progression (\nFigure 1\n).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Molecular genetic studies have examined AK and cSCC for known cancer gene expressions, chromosomal instability, and mutation levels (\nFigure 2\n).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Schematic depicting the spectrum of morphologies of NS-AK-cSCC lesions, with relevant changes in gene expression.Figure 2.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Below is an overview of the current clinical drugs used in the management of AK and cSCC (\nFigure 3\n).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Identifying specific genomic changes that drive the transition from normal skin (NS) to AK and subsequently to invasive cSCC is challenging, given the substantial burden of UVR-induced mutations characteristic of all stages of this progression (\nFigure 1\n).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Molecular genetic studies have examined AK and cSCC for known cancer gene expressions, chromosomal instability, and mutation levels (\nFigure 2\n).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Schematic depicting the spectrum of morphologies of NS-AK-cSCC lesions, with relevant changes in gene expression.Figure 2.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Identifying specific genomic changes that drive the transition from normal skin (NS) to AK and subsequently to invasive cSCC is challenging, given the substantial burden of UVR-induced mutations characteristic of all stages of this progression (\nFigure 1\n).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Molecular genetic studies have examined AK and cSCC for known cancer gene expressions, chromosomal instability, and mutation levels (\nFigure 2\n).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Below is an overview of the current clinical drugs used in the management of AK and cSCC (\nFigure 3\n).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Below is an overview of the current clinical drugs used in the management of AK and cSCC (\nFigure 3\n).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  }
]